Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$7.79 USD

7.79
1,013,423

+0.04 (0.52%)

Updated May 10, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 251)

Industry: Technology Services

Better trading starts here.

Zacks News

MDRX vs. HMSY: Which Stock Is the Better Value Option?

MDRX vs. HMSY: Which Stock Is the Better Value Option?

Veeva Systems to Improve Patient Outcome With Crossix Buyout

The latest acquisition fortifies Veeva Systems' (VEEV) foothold in the HCIT space further.

NextGen's (NXGN) Population Health Picked by Ohio-Based UH

NextGen's (NXGN) EHR services are expected to enhance patient outcomes at UH.

MDRX vs. HMSY: Which Stock Is the Better Value Option?

MDRX vs. HMSY: Which Stock Is the Better Value Option?

Is AllScripts Healthcare (MDRX) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

AllScripts (MDRX) Down 9.5% Since Last Earnings Report: Can It Rebound?

AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MDRX vs. HMSY: Which Stock Should Value Investors Buy Now?

MDRX vs. HMSY: Which Stock Is the Better Value Option?

Allscripts Inks Deal With Apple for Electronic Health Record

Allscripts (MDRX) is working toward providing compact health records.

Sreyoshi Mukherjee headshot

Bright Near-Term Outlook for Medical Info Systems Industry

Growth prospects look bright for the Zacks Medical Info Systems industry, thanks to rising need for curtailing medical expenses and AI.

Allscripts' (MDRX) Veradigm Collaborates With Komodo Health

Allscripts (MDRX) expects its Veradigm business to drive bookings in 2019.

Here's Why You Should Invest in Cooper Companies Stock Now

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions.

MDRX vs. NXGN: Which Stock Is the Better Value Option?

MDRX vs. NXGN: Which Stock Is the Better Value Option?

Here's Why You Should Invest in HMS Holdings (HMSY) Stock Now

HMS Holdings (HMSY) is gaining traction from the growing PI and TPM analytical services as well as robust margins.

Allscripts (MDRX) Q2 Earnings Top Estimates, Revenues Lag

Allscripts (MDRX) second-quarter results gain from growth in bookings and solid show by client services segment. Contraction in operating margin remains a woe.

AllScripts Healthcare (MDRX) Beats Q2 Earnings Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of 6.25% and -0.72%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: AllScripts Healthcare (MDRX) Q2 Earnings Expected to Decline

AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MDRX or CERN: Which Is the Better Value Stock Right Now?

MDRX vs. CERN: Which Stock Is the Better Value Option?

MDRX vs. CERN: Which Stock Should Value Investors Buy Now?

MDRX vs. CERN: Which Stock Is the Better Value Option?

Here's Why You Should Retain Allscripts (MDRX) Stock Now

Allscripts (MDRX) is gaining steadily from strategic acquisitions and solid prospects in Sunrise EHR platform. However, integration risks remain a woe.

Ecolab's (ECL) New Digital Dashboards to Improve Healthcare

Ecolab's (ECL) Hand Hygiene Compliance Monitoring System connects with digital dashboards.

Why Is AllScripts (MDRX) Up 1.6% Since Last Earnings Report?

AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Allscripts (MDRX) Q1 Earnings Beat Estimates, Revenues Miss

Allscripts (MDRX) Q1 results gain from growth in bookings and solid show by client services segment. Contraction in margins remains a woe.

AllScripts Healthcare (MDRX) Q1 Earnings Surpass Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of 14.29% and -1.02%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: AllScripts Healthcare (MDRX) Q1 Earnings Expected to Decline

AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Allscripts' FollowMyHealth Partners Ephraim McDowell Health

Allscripts' (MDRX) FollowMyHealth is an EHR-neutral patient engagement platform that allows patients to stay connected with their physicians.